Hypogammaglobulinemia due to CAR T‐cell therapy

E-ISSN： 1545-5017|65|4|pbc.26914-pbc.26914

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.65, Iss.4, 2018-04, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The EURE‐CART project as a prototype model for CAR T‐cell immunotherapy in Europe

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 48, Iss. 2, 2018-02 ,pp. : 216-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adoptive T-Cell Therapy for EBV-Associated Post-Transplant Lymphoproliferative Disease

Acta Haematologica, Vol. 110, Iss. 2-3, 2003-10 ,pp. : 139-148

Karger

Access to resources Recommend Favorite

Adoptive regulatory T‐cell therapy protects against cerebral ischemia

ANNALS OF NEUROLOGY, Vol. 74, Iss. 3, 2013-09 ,pp. : 458-471

John Wiley & Sons Inc

Access to resources Recommend Favorite

IL-2-Inducible T-Cell Kinase Deficiency with Pulmonary Manifestations due to Disseminated Epstein-Barr Virus Infection

International Archives of Allergy and Immunology, Vol. 158, Iss. 4, 2012-04 ,pp. : 418-422

Karger

Access to resources Recommend Favorite

Pure Red Cell Aplasia Associated to Clonal CD8+ T-Cell Large Granular Lymphocytosis: Dependence on Cyclosporin A Therapy

Acta Haematologica, Vol. 100, Iss. 4, 1999-02 ,pp. : 207-210

Karger

Access to resources Recommend Favorite